Oryzon Genomics - Grants provide confidence and expand portfolio
Oryzon has announced that it has received two separate grants from the Spanish State Research Agency and the Ministry of Science and Innovation to...
259 Views
Oryzon Genomics - H123 progress and results came in as expected
Oryzon’s H123 results highlight the continued progress of its lead clinical-stage assets, including positive aggregate safety data from the Phase...
230 Views
Oryzon Genomics - Positive safety data for vafidemstat in PORTICO
Oryzon has announced positive aggregate safety data for vafidemstat, which is being evaluated in the ongoing PORTICO trial as a potential treatment...
285 Views
Oryzon Genomics - Advancing on multiple clinical fronts in Q1
Oryzon has reported Q123 results highlighting its near-term strategic priorities, including a favourable interim analysis of its lead asset study,...
224 Views
Oryzon Genomics - Promising PORTICO interim results
Oryzon has announced promising results from an interim analysis of the Phase IIb PORTICO study, a trial evaluating vafidemstat as a treatment for...
271 Views